Form 4/A for STLN Starling Oncology, Inc.
Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-02 · accession 0001079973-26-000039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-01-06 | 2026-01-02 | STLN | Carter Robert Ross | CFO | J - Other | $3.67 | -244 | 235.1K | -0.1% | -$895.48 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-02 | J | D | 244 | $3.67 | 235,125 | D | — | — |